Showing results (21-30 of 621) with videos related to
Sort By:
Pageof 63
Neurological Research and Practice|August 17, 2021
Multiple sclerosis is not associated with an increased risk for severe COVID-19: a nationwide retrospective cross-sectional study from GermanyDaniel Richter, Simon Faissner, Dirk Bartig, et al.Frontiers in Immunology|April 21, 2025
Switching to ublituximab from prior anti-CD20 monoclonal antibody therapy: a case report seriesRegina Berkovich, Jonathan Calkwood, Heidi Crayton, et al.Therapeutic Advances in Neurological Disorders|July 21, 2021
The impact of the COVID-19 pandemic on hospitalizations and plasmapheresis therapy in multiple sclerosis and neuromyelitis optica spectrum disorder: a nationwide analysis from GermanyDaniel Richter, Simon Faissner, Dirk Bartig, et al.Brain and Behavior|February 28, 2015
"Liberation treatment" for chronic cerebrospinal venous insufficiency in multiple sclerosis: the truth will set you freeGeorgios Tsivgoulis, Simon Faissner, Konstantinos Voumvourakis, et al.Scientific Reports|August 1, 2024
Siponimod treatment response shows partial BDNF dependency in multiple sclerosis modelsHasan Hüseyin Hendek, Alina Blusch, Neele Heitmann, et al.Journal of Neurology|May 13, 2022
Hypoechogenicity of brainstem raphe in long-COVID syndrome-less common but independently associated with depressive symptoms: a cross-sectional studyDaniel Richter, Hannah Schulze, Jeyanthan Charles James, et al.Journal of Neuroinflammation|March 13, 2017
Teriflunomide and monomethylfumarate target HIV-induced neuroinflammation and neurotoxicityBjörn Ambrosius, Simon Faissner, Kirsten Guse, et al.Scientific Reports|January 11, 2025
Neurological post-COVID syndrome is associated with substantial impairment of verbal short-term and working memoryJeyanthan Charles James, Hannah Schulze, Nadine Siems, et al.Proceedings of the National Academy of Sciences of the United States of America|June 17, 2024
Successful use of anti-CD19 CAR T cells in severe treatment-refractory stiff-person syndromeSimon Faissner, Jeremias Motte, Melissa Sgodzai, et al.Frontiers in Neurology|October 31, 2022
Cross-sectional analysis of clinical aspects in patients with long-COVID and post-COVID syndromeHannah Schulze, Jeyanthan Charles James, Nadine Trampe, et al.Pageof 63